Medical and Health Science Journal

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Volume 13
Issue 4
Online publication date 2012-12-15
Title Evaluation of transplantation of mesenchymal cells in acute myocardial infarction
Author Aliya Dzholdasbekova, Galina Fedotovskikh, Daniyar Jumaniyazov, Nadezhda Popova, Bayan Komsabakova
Abstract It has been studied in the pilot clinical research the effect of systemic (intravenous) transplantation of mesenchymal stem cells (MSC) of a bone marrow to 20 patients with an acute myocardial infarction with lifting segment of ST (STEMI) carried out in the first 2 hours by percutaneous coronary intervention (PCI) with stenting infarct related artery and the common course of drug therapy. It has been shown that the transplantation of MSCs had not caused any complications (allergic reactions, hazardous to health arrhythmias, embolism and heavy frustration of hemodynamic) and had not lead to condition deterioration afterwards. In the first 3-6 months after systemic transplantation of MSCs to the patients’ heart contractive activity has been advanced which was clinically proved in the reduction of the heart failure level degree of expressiveness of warm insufficiency.
Citation
References
Carmeliet, P., Ng, YS., Nuyens, D., Theilmeier, G. et al., 1999. “Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188,” Nat. Med., Vol.5(5), pp.495-502

Eisenberg, L., Moreno, R., Markwald, R., 2005. “Multiple stem cell populations contribute to the formation of the myocardium,” Ann N Y Acad Sci., Vol.1047, pp.38-49

Golovkin, A., Velikanova, E., Matveeva, A. et al., 2011. “An assessment of mechanisms of therapy of a myocardial infarction stem mesenchymal cells in experiment,” IV All-Russian Conference “Stem Cells and Regenerative Medicine” [Otsenka mechanizmov terapii infarkta miokarda stvolovymi mezenchimalnymi kletkami v eksperimente ], in Russian

Iso, Y., Spees, J., Serano, C. et al., 2007. “Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment,” Biochem. Biophys. Res. Commun., Vol.354(3), pp.700-706

Kinnaird, T., Stabile, E., Burnett, M. et al., 2004. “Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms,” Circ Res.,Vol.94, pp.678-85

Kinnaird, T., Stabile, E., Epstein, S., Fuchs, S., 2003. “Current perspectives in therapeutic myocardial angiogenesis,” J.Interv.Cardiol., Vol.16, No.4, pp.289-97

Lee, R., Pulin, A., Seo, M. et al., 2009. “Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti inflommatory protein TSG-6,”  Cell.Stem.Cell.,Vol. 5(1), pp.54-63

Lough, J., Sugi, Y., 2000. “Endoderm and heart development,” Dev. Dyn., Vol.217(4), pp.327-42

Nakamura, T., Schneider, M., 2003. “The way to a human’s heart is through the stomach: visceral endoderm-like cells drive human embryonic stem cells to a cardiac fate,”  Circulation, Vol.107, pp.2638-639

Orlic, D., Kajstura, J., Chimenti, S. et al., 2001. “Mobilized bone marrow cells repair the infracted heart, improving function and survival,” Proc Natl Acad Sci U S A.,Vol.98(18), pp.10344-349

Sugi, Y., Markwald, R., 2003. “Endodermal growth factors promote endocardial precursor cell formation from precardiac mesoderm,” Dev. Biol., Vol.263(1), pp.35-49

Keywords Acute myocardial infarction, chronic heart failure, mesenchymal stem cells, angiogenesis, cell therapy
DOI http://dx.doi.org/10.15208/mhsj.2012.53
Pages 14-19
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Share
Search in articles
Statistics
Journal Published articles
MHSJ 940
Journal Hits
MHSJ 2214042
Journal Downloads
MHSJ 16962
Total users online -